Probeer een andere zoekopdracht
Naam | Leeftijd | Sinds | Titel |
---|---|---|---|
Philip Wagenheim | 53 | 2017 | Director |
George C. Prendergast | - | - | Member of Scientific Advisory Board |
Shmuel Shoham | - | 2020 | Member of COVID-19 Advisory Board |
Louis M. Weiner | 72 | - | Member of Scientific Advisory Board |
John M. Lambert | 73 | 2023 | Member of Antibody-Drug Conjugate & T Cell Redirection Advisory Board |
Isaac Barchas | 57 | 2023 | Lead Independent Director |
Jeffrey Henderson | - | 2020 | Member of COVID-19 Advisory Board |
Susan Weiss | - | 2020 | Member of COVID-19 Advisory Board |
Andrew D. Badley | - | 2021 | Member of COVID-19 Advisory Board |
William Strohl | 71 | - | Member of Scientific Advisory Board |
Anthony W. Tolcher | - | - | Member of Scientific Advisory Board and Member of ADC & T Cell Redirection Advisory Board |
Clay B. Siegall | 63 | 2023 | President, CEO & Chairman |
James Patrick Boylan | 56 | 2023 | Independent Director |
Carol A. Schafer | 60 | 2024 | Independent Director |
Sandra M. Swain | 69 | 2024 | Independent Director |
Jean-Jacques Bienaime | 71 | 2023 | Independent Director |
Weet u zeker dat u %USER_NAME% wilt blokkeren?
Als u dit doet, kunnen u en %USER_NAME% geen publicaties meer van elkaar zien op Investing.com.
%USER_NAME% is toegevoegd aan uw lijst met geblokkeerde personen
Omdat u de blokkering van deze persoon net hebt opgeheven, moet u 48 uur wachten om hem/haar weer te kunnen blokkeren.
Ik vind dit commentaar
Bedankt!
Uw bericht is ter beoordeling verstuurd naar de moderatoren